GARY M PFEIFFER, a director at $DGX, sold 1,482 shares of the company on 10-22-2025 for an estimated $270,316. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.8% of their shares of this class of stock. Following this trade, they now own 29,431 shares of this class of $DGX stock.
$DGX Insider Trading Activity
$DGX insiders have traded $DGX stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $DGX stock by insiders over the last 6 months:
- MICHAEL E PREVOZNIK (SVP & General Counsel) has made 0 purchases and 4 sales selling 28,690 shares for an estimated $5,368,747.
- PATRICK PLEWMAN (SVP for Diagnostic Services) has made 0 purchases and 5 sales selling 14,017 shares for an estimated $2,518,856.
- KARTHIK KUPPUSAMY (SVP, Clinical Solutions) has made 0 purchases and 3 sales selling 10,479 shares for an estimated $1,759,930.
- MARK E DELANEY (SVP & Chief Commercial Officer) has made 0 purchases and 2 sales selling 1,748 shares for an estimated $306,800.
- GARY M PFEIFFER sold 1,482 shares for an estimated $270,316
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DGX Hedge Fund Activity
We have seen 456 institutional investors add shares of $DGX stock to their portfolio, and 429 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,210,459 shares (+20.2%) to their portfolio in Q2 2025, for an estimated $217,434,750
- DAVIS SELECTED ADVISERS removed 1,033,882 shares (-43.3%) from their portfolio in Q2 2025, for an estimated $185,716,223
- NORDEA INVESTMENT MANAGEMENT AB removed 1,029,219 shares (-81.9%) from their portfolio in Q2 2025, for an estimated $184,878,608
- M&G PLC added 771,824 shares (+256.5%) to their portfolio in Q2 2025, for an estimated $138,642,745
- BOSTON PARTNERS added 739,407 shares (+32.2%) to their portfolio in Q2 2025, for an estimated $132,819,679
- SQUAREPOINT OPS LLC added 688,297 shares (+444.1%) to their portfolio in Q2 2025, for an estimated $123,638,790
- JPMORGAN CHASE & CO added 561,722 shares (+14.9%) to their portfolio in Q2 2025, for an estimated $100,902,122
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DGX Analyst Ratings
Wall Street analysts have issued reports on $DGX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Leerink Partners issued a "Outperform" rating on 10/21/2025
- Jefferies issued a "Buy" rating on 10/21/2025
- Mizuho issued a "Outperform" rating on 10/17/2025
To track analyst ratings and price targets for $DGX, check out Quiver Quantitative's $DGX forecast page.
$DGX Price Targets
Multiple analysts have issued price targets for $DGX recently. We have seen 11 analysts offer price targets for $DGX in the last 6 months, with a median target of $195.0.
Here are some recent targets:
- David Macdonald from Truist Securities set a target price of $205.0 on 10/22/2025
- Stephanie Davis from Barclays set a target price of $195.0 on 10/22/2025
- Michael Cherny from Leerink Partners set a target price of $210.0 on 10/21/2025
- Tycho Peterson from Jefferies set a target price of $215.0 on 10/21/2025
- Kevin Caliendo from UBS set a target price of $190.0 on 10/17/2025
- Ann Hynes from Mizuho set a target price of $210.0 on 10/17/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $190.0 on 10/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
